clinical characteristic | ARID2 | CDKN2A | KRAS | NF1 | RB1 | TP53 | ||||||||||||
P | OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | |
Age (<60 vs. ≥60) | - | - | - | - | 0.040* | 3.331 | 1.056 - 10.501 | 0.002* | 2.498 | 1.418 - 4.400 | ||||||||
Sex (Male vs. Female) | - | - | - | - | - | 0.024* | 2.010 | 1.096 - 3.688 | ||||||||||
Race (Asian vs. non-Asian) | 0.078 | 3.945 | 0.856 - 18.173 | 0.060 | 7.310 | 0.922 - 57.810 | - | - | - | <0.001* | 5.696 | 2.824 - 11.491 | ||||||
Primary site (Liver vs. Bile duct) | - | - | 0.011* | 0.168 | 0.043 - 0.661 | - | - | 0.014* | 4.578 | 1.354 - 15.476 | ||||||||
Pathological typing | - | - |
|
|
|
| ||||||||||||
HCC | Reference | Reference | Reference | Reference | ||||||||||||||
ICC | 0.011* | 0.170 | 0.043 - 0.670 | 0.122 | 0.386 | 0.115 - 1.288 | − | 1.950E+07 | 1.950E+07 | 0.015* | 4.571 | 1.351 - 15.458 | ||||||
cHCC-ICC | - | 5.450E+06 | 5.450E+06 | 0.072 | 0.103 | 0.009 - 1.222 | 0.134 | 0.153 | 0.013 - 1.781 | 0.921 | 0.885 | 0.079 - 9.920 |